HHGA
STJ

Halbert Hargrove Global Advisors’s St Jude Medical STJ Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,944
Closed -$288K – 176
2015
Q2 		$288K Sell
3,944
-162
-4% -$11.7K 0.07% 143
2015
Q1 		$269K Buy
+4,106
New +$273K 0.09% 151

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Halbert Hargrove Global Advisors's STJ Position: Q3 2015 in Review

Halbert Hargrove Global Advisors sold out of St Jude Medical (STJ) in Q3 2015, closing a stake of 3,944 shares — an estimated $288K sold.

Halbert Hargrove Global Advisors first reported a position in STJ in Q1 2015 and held it in 2 quarters. The position peaked at $288K in Q2 2015. 618 funds tracked by Wall St. Rank hold STJ as of Q3 2015.

  • Halbert Hargrove Global Advisors reported no remaining St Jude Medical position as of Q3 2015 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 3,944 St Jude Medical shares in Q3 2015, an estimated $288K.
  • Halbert Hargrove Global Advisors first reported a position in St Jude Medical in Q1 2015 and held it in 2 quarters.
  • Halbert Hargrove Global Advisors's St Jude Medical position peaked at $288K in Q2 2015.
  • 618 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2015.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.